Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland

P. M. McKeigue*, D. Porter, R. J. Hollick, S. H. Ralston, D. A. McAllister, H. M. Colhoun

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland'. Together they form a unique fingerprint.

Medicine & Life Sciences